Monthly View Flat View Weekly View Daily View Categories

Events under 'CME Satellite Symposium'

Event NameEvent Date
Optimizing Outcomes in the Management of Narcolepsy and Obstructive Sleep ApneaFriday, September 16, 2016 (5:45PM)
AASM (American Academy of Sleep Medicine)Monday, June 05, 2017 (6:15PM)
Non-Statin Therapy for LDL Cholesterol Reduction in Primary and SecondaryPreventionFriday, February 23, 2018 (6:45PM)
Cardiovascular Risk Reduction and LDL-C: Evolving PerspectivesThursday, April 05, 2018 (8:00AM)
LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk ReductionThursday, April 19, 2018 (6:00PM)
Fine-tuning the Management of Narcolepsy & Excessive Daytime SleepinessMonday, June 04, 2018 (6:15PM)
Crossroads of Care: Facing the Challenges of Heart Failure and DiabetesThursday, July 19, 2018 (12:15PM)
Hyperkalemia and Heart Failure: Recognizing Risks and Exploring Strategies for Improving OutcomesFriday, July 20, 2018 (7:30AM)
Diabetes Therapies: Exploring Mechanisms and Role of the Cardio Clinician in CVD Risk MgtFriday, July 20, 2018 (2:30PM)
Overcoming Barriers in Hyperkalemia Management in Heart Failure: An Expert Summit - Nashville, TNSaturday, September 15, 2018 (12:15PM)
Diabetes Therapies and Cardiovasc Risk Reduction: Closer Look at SGLT2 Inhib - New Orleans, LATuesday, October 09, 2018 (6:00PM)
Narcolepsy in Children: Insights into Diagnosis and Strategies to Improve Patient Care - Chicago, ILWednesday, October 17, 2018 (8:00AM)
Managing LDL-C with PCSK9 Inhibitors: Identifying the Patients, Optimizing the OutcomesFriday, February 22, 2019 (6:45PM)
Reducing LDL-C and Cardiovascular Risk with Nonstatin Therapy: From Evidence to PracticeThursday, April 11, 2019 (6:00PM)
Treating High-Risk Patients With Non-Statin Therapy for LDL-C Lowering: Optimizing Clinical OutcomesFriday, April 12, 2019 (8:01AM)
CV Risk Reduction with SGLT2 Inhibitors and GLP-1 Receptor Agonists: Taking a Closer LookFriday, June 07, 2019 (6:30PM)
Tailoring LDL-C-Lowering Therapy to Patient Cardiovascular Risk: Identifying Effective StrategiesSunday, June 09, 2019 (6:45PM)
Narcolepsy and Excessive Daytime Sleepiness in OSA: Strategies to Improving OutcomesMonday, June 10, 2019 (6:15PM)
Cardiovascular, Metabolic, and Renal Outcomes in Multi-Morbid Heart Failure Patients with Type 2 DSaturday, September 14, 2019 (7:30AM)
Reducing Cardiovascular Risk and Renal Risk With SGLT2 Inhibitors: Exploring the EvidenceSunday, September 15, 2019 (6:30PM)
Waking Up to Narcolepsy: Strategies to Improving OutcomesMonday, September 23, 2019 (12:30PM)
Excessive Daytime Sleepiness in Patients with OSA: Impact, Causes, and Treatment StrategiesTuesday, September 24, 2019 (12:30PM)
Narcolepsy in Children: Overcoming Barriers and Improving OutcomesFriday, October 04, 2019 (12:00PM)
Narcolepsy in Children: Addressing the Challenges and Improving the OutcomesSaturday, November 16, 2019 (6:00PM)
Atherosclerotic Cardiovascular Disease, Heart Failure, and SGLT2 InhibitorsFriday, April 03, 2020 (7:30AM)
Reducing Cardiovascular and Renal Risk in Your Patients with Type 2 DiabetesWednesday, April 22, 2020 (6:00PM)
The Heart, the Kidney, and SGLT2 Inhibition: From Clinical Trials to Patient CareSaturday, November 14, 2020 (5:00PM)
27 Event(s)